Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
US FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED
Published on May 21, 2025
The drop has the potential to become the first-ever ocular surface indication for an IG.
Continue reading on website
Other news
UK Study Finds Optometrist-Performed SLT Safe, Effective
May 21, 2025
A study on the safety and efficacy of more than 850 SLT procedures performed by three optometrists in the United Kingdom revealed a high success rate and minimal complications, affirming the proficiency of ODs in administering this first-line treatment for glaucoma and ocular hypertension. Photo: Nate Lighthizer, OD. Click image to enlarge. In recent years, selective laser t
Bausch + Lomb launches LUMIFY Preservative Free redness reliever eye drops in US
May 21, 2025
The OTC eye drops contain low-dose brimonidine tartrate 0.025%.